D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder

被引:137
|
作者
Storch, Eric A. [1 ]
Merlo, Lisa J.
Bengtson, Michael
Murphy, Tanya K.
Lewis, Mark H.
Yang, Mark C.
Jacob, Marni L.
Larson, Michael
Hirsh, Adam
Fernandez, Melanie
Geffken, Gary R.
Goodman, Wayne K.
机构
[1] Univ Florida, Dept Psychiat, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Pediat, Gainesville, FL 32610 USA
[3] Univ Florida, Dept Stat, Gainesville, FL 32610 USA
[4] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32610 USA
关键词
D-cycloserine; exposure-response prevention therapy; obsessive-compulsive disorder; treatment;
D O I
10.1097/YIC.0b013e32819f8480
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Obsessive-compulsive disorder is a common, chronic, and oftentimes disabling disorder. The only established first-line treatments for obsessive-compulsive disorder are exposure and response prevention therapy and the serotonin reuptake inhibitors. Many patients do not experience complete symptom resolution with either modality and require augmentation approaches. Recent animal and clinical data suggest that D-cycloserine, a partial agonist that acts at the strychnine-insensitive glycine-recognition site of the N-methyl-D-aspartate receptor complex, may enhance extinction learning that occurs in exposure-based psychotherapies. Given this, this study examined if D-cycloserine (250 mg) enhances the overall efficacy and rate of change of exposure and response prevention therapy for adult obsessive-compulsive disorder. Participants were 24 adults meeting Diagnostic and Statistical Manual of Mental Disorders-IV criteria for obsessive-compulsive disorder. The study design was a randomized, double-blinded, placebo-controlled augmentation trial examining exposure and response prevention therapy+ D-cycloserine versus exposure and response prevention therapy+ placebo. All patients received 12 weekly sessions of exposure and response prevention treatment. The first session involved building a ritual hierarchy and providing psychoeducation about obsessive-compulsive disorder. The second session involved a practice exposure. Sessions 3-12 involved exposure and response prevention exercises. D-cycloserine or placebo (250 mg) was taken 4 h before every session. No significant group differences were found across outcome variables. The rate of improvement did not differ between groups. The present results fail to support the use Of D-cycloserine with exposure and response prevention therapy for adult obsessive-compulsive disorder. As this study is the first to explore this question and a number of methodological issues must be considered when interpreting the findings, the conclusions that may be drawn from our results are limited.
引用
收藏
页码:230 / 237
页数:8
相关论文
共 50 条
  • [41] Pilot study of exposure and response prevention for Japanese patients with obsessive-compulsive disorder
    Shinmei, Issei
    Kanie, Ayako
    Kobayashi, Yuki
    Nakayama, Noriko
    Takagishi, Yuriko
    Iijima, Sonoko
    Takebayashi, Yoshitake
    Horikoshi, Masaru
    JOURNAL OF OBSESSIVE-COMPULSIVE AND RELATED DISORDERS, 2017, 15 : 19 - 26
  • [42] Concentrated exposure and response prevention for adolescents with obsessive-compulsive disorder: An effectiveness study
    Riise, Eili N.
    Kvale, Gerd
    Ost, Lars-Goran
    Skjold, Solvei Harila
    Hansen, Hans
    Hansen, Bjarne
    JOURNAL OF OBSESSIVE-COMPULSIVE AND RELATED DISORDERS, 2016, 11 : 13 - 21
  • [43] Concentrated exposure and response prevention for adolescents with obsessive-compulsive disorder: A replication study
    Riise, Eili N.
    Kvale, Gerd
    Ost, Lars-Goran
    Skjold, Solvei Harila
    Hansen, Bjarne
    JOURNAL OF OBSESSIVE-COMPULSIVE AND RELATED DISORDERS, 2018, 19 : 15 - 22
  • [44] Cognitive Mediation of Symptom Change in Exposure and Response Prevention for Obsessive-Compulsive Disorder
    Su, Yi-Jen
    Carpenter, Joseph K.
    Zandberg, Laurie J.
    Simpson, Helen Blair
    Foa, Edna B.
    BEHAVIOR THERAPY, 2016, 47 (04) : 474 - 486
  • [45] Comorbidity of obsessive-compulsive disorder with obsessive-compulsive personality disorder: Does it imply a specific subtype of obsessive-compulsive disorder?
    Garyfallos, George
    Katsigiannopoulos, Konstantinos
    Adamopoulou, Aravela
    Papazisis, Georgios
    Karastergiou, Anastasia
    Bozikas, Vasilios P.
    PSYCHIATRY RESEARCH, 2010, 177 (1-2) : 156 - 160
  • [46] Is exposure and response prevention treatment for obsessive-compulsive disorder as aversive as we think?
    Lee, Yong Heng
    Rees, Clare S.
    CLINICAL PSYCHOLOGIST, 2011, 15 (01) : 17 - 21
  • [47] The efficacy of teaching psychology students exposure and response prevention for obsessive-compulsive disorder
    Solem, Stian
    Hansen, Bjarne
    Vogel, Patrick A.
    Kennair, Leif Edward Ottesen
    SCANDINAVIAN JOURNAL OF PSYCHOLOGY, 2009, 50 (03) : 245 - 250
  • [48] Utilizing Exposure and Response Prevention to Address Poor Insight in Obsessive-Compulsive Disorder
    Middleton, Rachel R.
    Hezel, Dianne M.
    JOURNAL OF COGNITIVE PSYCHOTHERAPY, 2019, 33 (03) : 213 - 227
  • [49] Extinction and beyond: an expanded framework for exposure and response prevention for obsessive-compulsive disorder
    Berg, Hannah
    Webler, Ryan D.
    Klein, Samuel
    Kushner, Matt G.
    FRONTIERS IN PSYCHOLOGY, 2024, 15
  • [50] Satiation therapy and exposure response prevention in the treatment of obsessive compulsive disorder
    Khodarahimi S.
    Journal of Contemporary Psychotherapy, 2009, 39 (3) : 203 - 207